...
首页> 外文期刊>Kidney and blood pressure research >Angiogenin: A Novel Inhibitor of Neutrophil Lactoferrin Release during Extracorporeal Circulation.
【24h】

Angiogenin: A Novel Inhibitor of Neutrophil Lactoferrin Release during Extracorporeal Circulation.

机译:血管生成素:体外循环过程中中性粒细胞乳铁蛋白释放的新型抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Degranulation of polymorphonuclear leukocytes (PMNL) occurs during extracorporeal circulation. A degranulation-inhibiting protein identical to angiogenin was recently isolated from high-flux dialyzer ultrafiltrate. This protein inhibits the release of lactoferrin and metalloproteinases from PMNL in vitro. In the present study, we investigated end-stage renal disease patients undergoing regular hemodialysis treatment with either high-flux dialyzers (n = 51) or low-flux dialyzers (n = 44), and chronically uremic patients undergoing hemodiafiltration (n = 30). Hemodialysis therapy with low-flux polysulfone or cellulose triacetate membranes caused no or only minimal reduction (
机译:多形核白细胞(PMNL)的脱粒发生在体外循环中。最近从高通量透析器超滤液中分离出了与血管生成素相同的脱颗粒抑制蛋白。该蛋白在体外抑制从PMNL释放乳铁蛋白和金属蛋白酶。在本研究中,我们调查了接受高通量透析器(n = 51)或低通量透析器(n = 44)接受常规血液透析治疗的终末期肾病患者以及接受血液透析滤过(n = 30)的慢性尿毒症患者。 。低通量聚砜或三醋酸纤维素膜的血液透析疗法在透析治疗后2小时内未引起血浆血管生成素水平降低或仅有极少降低(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号